That is, while HDAC inhibitors undoubtedly work to restore expression of tumor-suppressors and other genes that are detrimental to the cancer, these inhibitors are quite likely to activate a variety of other genes that could promote the progression of the cancer. This evidence concerns the gene HDAC9 and neoplasm.